Aflibercept‑Ayyh Suppliers & Bulk Manufacturers

Available Forms: Intravitreal injection (liquid solution)

Available Strengths: 2 mg/0.05 mL

Reference Brands: Eylea(US & EU); Pavblu - biosimilar to biosimilar to Eylea

Category: Biosimilars

Aflibercept‑ayyh is available in Intravitreal injection (liquid solution) and strengths such as 2 mg/0.05 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Aflibercept‑ayyh is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Aflibercept‑ayyh can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Pavblu, a biosimilar of Eylea (aflibercept), is regulated in the EU and US with dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval involves extensive comparability data, validation, and clinical validation. In the EU, CE marking certifies conformity under MDR standards. These biosimilars undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, high-quality ophthalmic biosimilars supporting effective treatment of eye diseases worldwide.